- Scheme Category:
- Equity Scheme >
- Sectoral/Thematic Funds
NAV: ₹ ↓ -0.54%
NAV chart
SMA (Simple Moving Average)
- 50 SMA
- 100 SMA
- 200 SMA
- 400 SMA
Returns
CAGR returns till date
CAGR returns of Tata India Pharma & Healthcare Fund-Direct Plan-Growth and its peers as on 11 September, 2026| Name | YTD | 1D | 1W | 1M | 3M | 1Y | 3Y | 5Y | 7Y | 10Y |
|---|---|---|---|---|---|---|---|---|---|---|
| Tata India Pharma & Healthcare Fund-Direct Plan-Growth | 11.1% | -0.54% | -0.68% | -2.27% | 6.67% | 8.63% | 19.67% | 14.61% | 22.43% | 14.72% |
| SBI CONSUMPTION OPPORTUNITIES FUND - DIRECT PLAN - GROWTH | -9.55% | -0.61% | -1.77% | -6.48% | 0.55% | -13.4% | 4.69% | 12.12% | 15.55% | 13.48% |
| SBI ESG Exclusionary Strategy Fund - Direct Plan -Growth | -5.09% | -0.49% | -2.13% | -4.09% | 3.04% | -1.59% | 8.1% | 8.16% | 13.27% | 11.45% |
| SBI HEALTHCARE OPPORTUNITIES FUND - DIRECT PLAN -GROWTH | 25.1% | -0.28% | 0.76% | -0.34% | 11.62% | 21.41% | 24.25% | 18.68% | 25.98% | 14.82% |
| SBI INFRASTRUCTURE FUND - DIRECT PLAN - GROWTH | 0.9% | -0.52% | -0.99% | -2.51% | 2.23% | 4.49% | 13.03% | 16.01% | 19.85% | 15.13% |
| SBI COMMA Fund - DIRECT PLAN - Growth | 6.56% | -1.27% | -2.15% | -0.7% | 4.16% | 12.2% | 15.12% | 11.14% | 20.13% | 15.56% |
Discrete returns (yearly)
| Year | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Returns | -12.74% | 5.85% | -0.68% | 7.04% | 67.87% | 19.94% | -6.85% | 39.53% | 42.49% | -3.93% |
Discrete returns (monthly)
| Month | Nov 2025 | Dec 2025 | Jan 2026 | Feb 2026 | Mar 2026 | Apr 2026 | May 2026 | Jun 2026 | Jul 2026 | Aug 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Returns | 0.22% | -1.64% | -5.6% | 4.93% | -6.3% | 6.93% | 3.25% | 4.52% | 4.39% | 0.65% |
Returns from spefic dates
| Description | CAGR returns from 18 Oct 2021 (Nifty 50 2021 high) | CAGR returns from 26 Sep 2024 (Nifty 50 2024 high) |
|---|---|---|
| Returns | 15.12% | 4.86% |
Portfolio
Asset allocation
| Equity | Debt | Realestate | Commodities | Cash & Equivalents |
|---|---|---|---|---|
| 99.13% | 0.00% (Arbitrage: 0.00%) | 0.00% | 0.00% | 0.87% |
Equity
| Name | Symbol / ISIN | Sector | Weight % | Other links |
|---|---|---|---|---|
| SUN PHARMACEUTICAL INDUSTRIES LTD | SUNPHARMA (INE044A01036) | Pharmaceuticals & Biotechnology | 8.59% | |
| DIVI LABORATORIES LTD | DIVISLAB (INE361B01024) | Pharmaceuticals & Biotechnology | 6.36% | |
| HEALTHCARE GLOBAL ENTERPRISES LTD | HCG (INE075I01017) | Healthcare Services | 5.85% | |
| ABBOTT INDIA LTD | ABBOTINDIA (INE358A01014) | Pharmaceuticals & Biotechnology | 5.63% | |
| RAINBOW CHILDRENS MEDICARE LTD | RAINBOW (INE961O01016) | Healthcare Services | 4.90% | |
| GLAXOSMITHKLINE PHARMACEUTICALS LTD | GLAXO (INE159A01016) | Pharmaceuticals & Biotechnology | 4.66% | |
| CIPLA LTD | CIPLA (INE059A01026) | Pharmaceuticals & Biotechnology | 4.53% | |
| DR REDDYS LABORATORIES LTD | DRREDDY (INE089A01031) | Pharmaceuticals & Biotechnology | 4.25% | |
| MAX HEALTHCARE INSTITUTE LTD | MAXHEALTH (INE027H01010) | Healthcare Services | 4.07% | |
| APOLLO HOSPITALS ENTERPRISE LTD | APOLLOHOSP (INE437A01024) | Healthcare Services | 3.90% | |
| BAYER CROPSCIENCE LTD | BAYERCROP (INE462A01022) | Fertilizers & Agrochemicals | 3.26% | |
| FORTIS HEALTHCARE LTD | FORTIS (INE061F01013) | Healthcare Services | 3.12% | |
| PFIZER LTD | PFIZER (INE182A01018) | Pharmaceuticals & Biotechnology | 3.06% | |
| MANKIND PHARMA LTD | MANKIND (INE634S01028) | Pharmaceuticals & Biotechnology | 3.02% | |
| SYNGENE INTERNATIONAL LTD | SYNGENE (INE398R01022) | Healthcare Services | 2.95% | |
| SAI LIFE SCIENCES LTD | SAILIFE (INE570L01029) | Pharmaceuticals & Biotechnology | 2.89% | |
| LUPIN LTD | LUPIN (INE326A01037) | Pharmaceuticals & Biotechnology | 2.64% | |
| ALKEM LABORATORIES LTD | ALKEM (INE540L01014) | Pharmaceuticals & Biotechnology | 2.58% | |
| PROCTER & GAMBLE HEALTH LTD | PGHL (INE199A01012) | Pharmaceuticals & Biotechnology | 2.42% | |
| FDC LTD | FDC (INE258B01022) | Pharmaceuticals & Biotechnology | 2.39% | |
| DR. LAL PATH LABS LTD | LALPATHLAB (INE600L01024) | Healthcare Services | 2.17% | |
| GLOBAL HEALTH LTD | MEDANTA (INE474Q01031) | Healthcare Services | 2.13% | |
| CONCORD BIOTECH LTD | CONCORDBIO (INE338H01029) | Pharmaceuticals & Biotechnology | 1.91% | |
| SUMITOMO CHEMICAL INDIA LTD | SUMICHEM (INE258G01013) | Fertilizers & Agrochemicals | 1.59% | |
| AJANTA PHARMA LTD | AJANTPHARM (INE031B01049) | Pharmaceuticals & Biotechnology | 1.53% | |
| NEULAND LABORATORIES LTD | NEULANDLAB (INE794A01010) | Pharmaceuticals & Biotechnology | 1.25% | |
| GILLETTE INDIA LTD | GILLETTE (INE322A01010) | Personal Products | 1.15% | |
| METROPOLIS HEALTHCARE LTD | METROPOLIS (INE112L01020) | Healthcare Services | 1.12% | |
| MANIPAL HEALTH ENTERPRISES LTD | (INE459N01021) | Healthcare Services | 0.97% | |
| BASF INDIA LTD | BASF (INE373A01013) | Chemicals & Petrochemicals | 0.97% | |
| JUBILANT PHARMOVA LTD | JUBLPHARMA (INE700A01033) | Pharmaceuticals & Biotechnology | 0.83% | |
| DR. AGARWALS HEALTH CARE LTD | AGARWALEYE (INE943P01029) | Healthcare Services | 0.67% | |
| SANOFI CONSUMER HEALTHCARE INDIA LTD | SANOFICONR (INE0UOS01011) | Pharmaceuticals & Biotechnology | 0.55% | |
| BIOCON LTD | BIOCON (INE376G01013) | Pharmaceuticals & Biotechnology | 0.52% | |
| ZIM LABORATORIES LTD | ZIMLAB (INE518E01015) | Pharmaceuticals & Biotechnology | 0.46% | |
| SANOFI INDIA LTD | SANOFI (INE058A01010) | Pharmaceuticals & Biotechnology | 0.23% | |
| ANTHEM BIOSCIENCES LTD | ANTHEM (INE0CZ201020) | Pharmaceuticals & Biotechnology | 0.01% |
Debt
| Name | Rating | Weight % |
|---|
Portfolio data is as on date 31 July, 2026
NAV history
Tata India Pharma & Healthcare Fund-Direct Plan-Growth - 30 days NAV (Net asset value) history
| Date | NAV | % change |
|---|---|---|
| 11 September, 2026 | 39.2439 | -0.54% |
| 10 September, 2026 | 39.4588 | -0.26% |
| 9 September, 2026 | 39.5623 | 0.08% |
| 8 September, 2026 | 39.5299 | -0.04% |
| 7 September, 2026 | 39.5473 | 0.09% |
| 4 September, 2026 | 39.5136 | -0.49% |
| 3 September, 2026 | 39.7071 | 0.05% |
| 2 September, 2026 | 39.6889 | -0.18% |
| 1 September, 2026 | 39.7621 | -0.71% |
| 31 August, 2026 | 40.0470 | 0.29% |
| 28 August, 2026 | 39.9296 | -0.21% |
| 27 August, 2026 | 40.0126 | 0.03% |
| 26 August, 2026 | 39.9990 | 0.12% |
| 25 August, 2026 | 39.9515 | 0.59% |
| 24 August, 2026 | 39.7181 | -0.05% |
| 21 August, 2026 | 39.7376 | -0.12% |
| 20 August, 2026 | 39.7847 | -0.16% |
| 19 August, 2026 | 39.8493 | 0.19% |
| 18 August, 2026 | 39.7747 | 0.39% |
| 17 August, 2026 | 39.6203 | -0.26% |
| 14 August, 2026 | 39.7249 | -0.15% |
| 13 August, 2026 | 39.7848 | -0.4% |
| 12 August, 2026 | 39.9426 | -0.53% |
| 11 August, 2026 | 40.1562 | 0.25% |
| 10 August, 2026 | 40.0575 | 0.28% |
| 7 August, 2026 | 39.9437 | -0.04% |
| 6 August, 2026 | 39.9592 | -0.06% |
| 5 August, 2026 | 39.9832 | -0.13% |
| 4 August, 2026 | 40.0337 | -0.2% |
| 3 August, 2026 | 40.1138 |
FAQ (Frequently asked questions)
What is latest/current NAV/price of Tata India Pharma & Healthcare Fund-Direct Plan-Growth?
The latest NAV of Tata India Pharma & Healthcare Fund-Direct Plan-Growth is 39.2439 as on 11 September, 2026.What are YTD (year to date) returns of Tata India Pharma & Healthcare Fund-Direct Plan-Growth?
The YTD (year to date) returns of Tata India Pharma & Healthcare Fund-Direct Plan-Growth are 11.1% as on 11 September, 2026.What are 1 year returns of Tata India Pharma & Healthcare Fund-Direct Plan-Growth?
The 1 year returns of Tata India Pharma & Healthcare Fund-Direct Plan-Growth are 8.63% as on 11 September, 2026.What are 3 year CAGR returns of Tata India Pharma & Healthcare Fund-Direct Plan-Growth?
The 3 year annualized returns (CAGR) of Tata India Pharma & Healthcare Fund-Direct Plan-Growth are 19.67% as on 11 September, 2026.What are 5 year CAGR returns of Tata India Pharma & Healthcare Fund-Direct Plan-Growth?
The 5 year annualized returns (CAGR) of Tata India Pharma & Healthcare Fund-Direct Plan-Growth are 14.61% as on 11 September, 2026.What are 10 year CAGR returns of Tata India Pharma & Healthcare Fund-Direct Plan-Growth?
The 10 year annualized returns (CAGR) of Tata India Pharma & Healthcare Fund-Direct Plan-Growth are 14.61% as on 11 September, 2026.What is LTCG (Long term capital gain) and STCG (Short term capital gain) tax for Tata India Pharma & Healthcare Fund-Direct Plan-Growth?
Tata India Pharma & Healthcare Fund-Direct Plan-Growth is equity oriented mutual fund. Various capital gain taxes are applicable as below (Effective for redemption after July 23, 2024 and from FY 2024-25)Holding period Tax rate Less than 1 year (STCG) 20% More than 1 year (LTCG) Tax free upto Rs. 1.25 lakhs. 12.5% on rest amount.